CXXIF (C21 Investments) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is C21 Investments 5-Year EBITDA Growth Rate?

C21 Investments's EBITDA per Share for the three months ended in Dec. 2024 was $0.01.

During the past 12 months, C21 Investments's average EBITDA Per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of C21 Investments was 59.30% per year. The lowest was -156.80% per year. And the median was 9.40% per year.

Competitive Comparison of C21 Investments's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C21 Investments's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where C21 Investments's 5-Year EBITDA Growth Rate falls into.

C21 Investments 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

C21 Investments (OTCPK:CXXIF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

C21 Investments 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of C21 Investments's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

C21 Investments Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (OTCPK:CXXIF) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CXXI:Canada

Address

601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1

Website

https://www.cxxi.ca

C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.